[Concept of endocrine ophthalmopathies].
D013956:Antithyroid Agents; D005094:Exophthalmos / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D006111:Graves Disease / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications; D008135:Long-Acting Thyroid Stimulator; D008297:Male; D008713:Methimazole / Q000627:therapeutic use; D009886:Ophthalmoplegia / Q000150:complications; D011241:Prednisone / Q000627:therapeutic use; D013960:Thyroid Function Tests; D013973:Thyrotropin-Releasing Hormone
D013956:Antithyroid Agents; D008713:Methimazole; D013973:Thyrotropin-Releasing Hormone; D008135:Long-Acting Thyroid Stimulator; D011241:Prednisone
Zum Begriff der endokrinen Opthalmopathie